At critical times in development, cells are able to convert graded signals into discrete developmental outcomes; however, the mechanisms involved are poorly understood. During thymocyte development, cell fate is determined by signals originating from the ab T-cell receptor. Low-affinity/avidity interactions between the T-cell receptor and peptide-MHC complexes direct differentiation to the single-positive stage (positive selection), whereas high-affinity/avidity interactions induce death by apoptosis (negative selection) 1, 2 . Here we show that mice deficient in both calcineurin and nuclear factor of activated T cells (NFAT)c2/c3 lack a population of preselection thymocytes with enhanced ability to activate the mitogen-activated protein kinase (Raf-MEK-ERK) pathway, and fail to undergo positive selection. This defect can be partially rescued with constitutively active Raf, indicating that calcineurin controls MAPK signalling. Analysis of mice deficient in both Bim (which is required for negative selection) and calcineurin revealed that calcineurin-induced ERK (extracellular signal-regulated kinase) sensitization is required for differentiation in response to 'weak' positive selecting signals but not in response to 'strong' negative selecting signals (which normally induce apoptosis). These results indicate that early calcineurin/ NFAT signalling produces a developmental period of ERK hypersensitivity, allowing very weak signals to induce positive selection. This mechanism might be generally useful in the discrimination of graded signals that induce different cell fates.
The calcineurin/NFAT 3, 4 and the Raf-MEK-ERK [5] [6] [7] pathways have been shown to be required for positive selection of thymocytes but not for their negative selection. Calcineurin B1 (Cnb1)-deficient CD4
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1 double-positive thymocytes lack calcineurin activity, fail to dephosphorylate NFATc transcription factors and are not positively selected ( Fig. 1a and ref. 3). Cnb1-deficient thymocytes have normal phosphorylation of JNK (c-Jun N-terminal kinase), p38, protein kinase C-h, protein kinase D and glycogen synthase kinase 3a after crosslinking of the T-cell receptor (TCR) (Fig. 1b and ref. 3). Actin polymerization and Ca 21 influx were also normal in these cells ( Supplementary Fig. 2a, b) . Collectively, these results indicated that Cnb1-deficient thymocytes did not have widespread signalling defects downstream of the TCR. However, Cnb1-deficient thymocytes showed a specific and severe defect in ERK1/2 phosphorylation (Fig. 1c) , resulting in almost undetectable induction of the ERK/Elk4 target gene Egr1 (ref. 6) after engagement of the TCR (Fig.1d) .In addition, both MAP-kinasekinase (MEK)1/2and Raf activation were defective in Cnb1-deficient double-positive thymocytes (Fig. 1c , e, f) after stimulation by crosslinking of the TCR.
To test whether calcineurin activity was directly required for Raf activation, we stimulated thymocytes in the presence of the calcineurin inhibitor cyclosporin A (CsA) or the MEK1/2 inhibitor required during development to acquire the ability to activate ERK1/2 properly in response to subsequent TCR signalling.
Cnb1-deficient
When ERK1/2 phosphorylation was assayed by intracellular staining, two populations with different levels of ERK1/2 phosphorylation were observed in control double-positive CD69-negative thymocytes after crosslinking with anti-CD3e antibody. The population of thymocytes with the higher level of ERK1/2 phosphorylation was absent in Cnb1-deficient and CsA-treated mice ( Fig. 2c and Supplementary  Fig. 3b ). The specificity of the staining and uniformity of crosslinking was confirmed by pretreating the cells with UO126 and by counterstaining for anti-CD3e, respectively ( Supplementary Fig. 3c, d ). We also examined the expression of TCR-b on Cnb1-deficient and control thymocytes and found no difference in the percentage of thymocytes with intermediate levels of TCR-b expression (double-positive TCR-b int ), a population that is absent from mice that fail to rearrange the TCR-a chain [8] [9] [10] ( Supplementary Fig. 3e ). We concluded that two thymocyte populations existed, within the double-positive CD69-negative population, with different abilities to phosphorylate ERK1/2 and that calcineurin activity was required for the presence of the population with an increased ability to phosphorylate ERK1/2. We refer to these populations as 'ERK low competence' and 'ERK high competence' populations, respectively.
We used a single bromodeoxyuridine (BrdU) pulse to mark developing thymocytes 11 and establish the precursor/progeny relationship of these two populations. At early time points, most BrdU-positive, double-positive thymocytes were in the 'ERK low competence' state, with the percentage of BrdU-positive 'ERK high competence' doublepositive thymocytes increasing over time (Fig. 2d, upper panel) . The transition to the 'ERK high competence' state was not observed in Cnb1-deficient thymocytes (Fig. 2d, lower panel) . These data indicated that the 'ERK low competence' state preceded the 'ERK high competence' state during normal thymocyte development and that calcineurin activity was required for this transition. The lag time for the development of the 'ERK high competence' population was consistent with a requirement for transcription.
Because the calcineurin phosphatase complex regulates the NFATc family of transcription factors 12, 13 , we analysed NFATc2/NFATc3 double-knockout thymocytes, which also have impaired positive selection 4 . The development of the 'ERK high competence' population was impaired in NFATc2/NFATc3 double-knockout thymocytes (Fig. 2e) , the incomplete block probably reflecting a partly redundant function of NFATc1. These data indicated that calcineurin/NFAT signalling was required for the transition to the 'ERK high competence' state. The developmental requirement for calcineurin and NFAT activity for normal activation of the ERK pathway was specific to thymocytes because short-term or long-term treatment with cyclosporin had no effect on peripheral T and B lymphocytes ( Supplementary Fig. 3f and data not shown). Analysis of MHCI/MHCII double-knockout mice revealed that the development of the 'high ERK competence' double-positive thymocyte population did not require TCR-MHC (major histocompatibility complex) interaction or positive selection ( Supplementary Fig. 4a ). Microarray analysis showed that 312 transcripts were differentially expressed in double-positive thymocytes from untreated and CsAtreated MHCI/MHCII double-knockout mice, indicating that calcineurin activity is required for preconditioning of double-positive thymocytes independently of positive selection ( Supplementary Fig.  4b , c, and Supplementary Table 1). We speculate that the development of the 'ERK high competence' population depends on pre-TCR signalling and/or ligand-independent tonic TCR-ab signalling and that the modulation of Raf activity could be due to a program of gene expression rather than a single modulator working at a single point in the pathway.
In vitro UO126
In vitro CsA
In vitro
If a main mechanism by which calcineurin controlled positive selection were by modulating the sensitivity of the Raf-MEK-ERK pathway, restoring Raf signalling in the absence of calcineurin activity should lead to at least a partial rescue of positive selection. To test this, we obtained mice whose thymocytes express a constitutively active Raf-1 mutant protein (Raf-CAAX transgenic mice 14 ), which does not induce positive selection in the absence of TCR signalling 14 . Mice were analysed between four and six weeks of age, before they developed any sign of thymic lymphoma. Long-term treatment with CsA completely blocked positive selection in control mice (Fig. 3a) . However, positive selection is rescued in CsA-treated Raf-CAAX mice as assessed by the upregulation of CD69 and TCR-b and the development of mature CD24 low Qa2 high single-positive CD4 and CD8 thymocytes (Fig. 3a-d) . Moreover, CD4 single-positive and CD8 single-positive thymocytes that are rescued in CsA-treated Raf-CAAX mice were able to respond functionally when stimulated with anti-CD3 and anti-CD28 antibodies ( Supplementary Fig. 5 ). Analogous results were obtained when Raf-CAAX was expressed in Cnb1-deficient thymocytes (Supplementary Fig. 6 ). As expected, the decreased thymic cellularity that is observed in the absence of calcineurin activity as a consequence of impaired transition from double negative to double positive was not rescued by the Raf-CAAX transgene ( Fig. 3e and Supplementary Fig. 6d ). Raf-CAAX only partly restores ERK phosphorylation in thymocytes from CsA-treated mice ( Supplementary Fig. 6e ). The fact that the Raf-CAAX transgene does not rescue the double-negative to double-positive developmental block and does not restore appropriate timing or intensity of ERK signalling, together with additional ERK-independent Cnb1/NFAT targets (such as the transcription factor TOX) (ref. 15) , might explain the incomplete rescue in Cnb1-deficient Raf-CAAX mice.
We proposed that this developmental window of ERK hypersensitivity might transiently increase the dynamic range (or bandwidth) of TCR signals, thereby enabling thymocytes to respond to 'weak' positively selecting ligands. To test this, we used the OT-I TAP (transporter associated with antigen processing)-null mice mouse model 16, 17 (OT-I TAP 0 ). We compared the ability of double-positive thymocytes from control and CsA-treated OT-I TAP 0 mice to respond to the negatively selecting peptide SIINFEKL and the positively selecting peptide RTYTYEKL (ref. 17) . OT-I-positive double-positive thymocytes from control mice responded to both peptides by phosphorylating ERK1/2, inducing Egr1 and upregulating CD69 (Fig. 4a-c and Supplementary Fig. 7 ). The response to the positively selecting peptide is weaker and delayed, as has been previously reported 18, 19 . In contrast, double-positive thymocytes from CsA-treated mice were able to respond partly to the negatively selecting peptide SIINFEKL but failed to respond to the positively selecting peptide RTYTYEKL (Fig. 4a-c and Supplementary Fig. 7 ). These data suggested that calcineurin-dependent ERK sensitization is required for a response to weaker positively selecting ligands, whereas stronger negative selecting signals are able to activate the ERK pathway to a certain extent even when the transition to the 'ERK high competence' state has not occurred.
If the role of calcineurin were to increase the 'signalling bandwidth' and allow effective discrimination of graded signals, one would predict that Cnb1-deficient thymocytes that were prevented from dying should be positively selected in response to stronger signals, which would normally induce cell death. To test this, we used mice deficient in Bim, which is necessary for negative selection 20 . In control mice, in vivo treatment with CsA completely blocked the development of single-positive thymocytes. However, differentiation occurred in Bim-deficient mice even in the absence of calcineurin activity as assessed by the development of TCR-b high CD4 single-positive and CD8 single-positive cells and upregulation of TCR-b, CD69 and CCR7 on double-positive cells (Fig. 4d and Supplementary Fig.  8a-c) . The double-negative to double-positive developmental block that is observed in CsA-treated and Cnb1-deficient thymocytes 3 , which results in an overall decrease in thymus cellularity in these mice, was not rescued by Bim deficiency (Supplementary Fig. 8c ). Analogous results were obtained when Bim-deficient mice were crossed with conditional Cnb1-deficient mice ( Supplementary Fig.  8d, e) . Because Bim deficiency did not rescue development of the 'ERK high competence' population itself ( Supplementary Fig. 8f ), we postulated that in Bim-deficient mice 'strong' negatively selecting ligands could trigger the activation of ERK in thymocytes that are in the 'ERK low competence' state. According to this hypothesis, in Bim-deficient mice negatively selecting ligands could circumvent the need for the calcineurin-dependent sensitization and could induce the differentiation of single-positive thymocytes that in normal circumstances are negatively selected. Indeed, analysis of Bim-deficient mice in a background (Balb/c) that expresses the MHC class II molecule I-E and allows the superantigen-mediated deletion of T cells (Fig. 4e) .
As a second approach to testing whether the role of ERK competence is to expand the signalling bandwidth, allowing the effective discrimination of weak signals, we examined thymocyte selection in the HY TCR transgenic mouse model. In this model most thymocytes express the HY TCR and are negatively selected by antigens expressed in male but not female mice 21 . As expected, the deletion of HY thymocytes in male mice (Supplementary Fig. 9a ) was impaired by Bim deficiency 20 . Because CsA treatment resulted in the accumulation of immature CD8 single-positive cells (Supplementary Fig. 9a ), we evaluated positive selection by monitoring CD69 upregulation and the development of CD24 low and Qa2 high CD8 single-positive cells. Treatment with CsA impaired CD69 upregulation and the development of mature CD8 single-positive thymocytes in control and Bimdeficient female mice, whereas it did not block the development of mature CD8 single-positive cells in male mice (Fig. 4f and Supplementary Fig. 9b, c) . Similar results were obtained in the HY CD4 model, in which TCR-ab expression is properly timed 22 (data not shown). These results suggested that the amount of ERK signalling provided by 'strong', negatively selecting signals in CsA-treated mice is able to induce differentiation and that negatively selecting signals do not require the development of 'ERK competence'.
Cell fate determination often occurs within morphogenic gradients that produce different cell fates at different points in the gradient, apparently as a result of signals of different intensities. A similar analogue-to-digital switch occurs in T-cell development ( Supplementary Fig. 1 ), where signal intensity determines the outcome of TCR-MHC interactions. Our studies indicate that an early calcineurin-NFAT signal sensitizes the Raf-MEK-ERK pathway, allowing responses to weak TCR signals that would otherwise not be detected (Supplementary Fig. 1 ). In the absence of this calcineurin-dependent preconditioning, the signal intensity needed for positive selection overlaps with that needed for negative selection, and effective discrimination of graded developmental signals cannot occur.
METHODS SUMMARY
Mice. Mice were maintained in the animal facility of Stanford University in accordance with federal and institutional guidelines and were used between 4 and 12 weeks of age unless otherwise noted. Cell isolation and flow cytometry. Cnb1-deficient and control double-positive thymocytes were routinely purified by anti-CD8a magnetic beads (Miltenyi Biotech) (purity more than 90%). Antibodies against CD markers, Q2a and CCR7 were from eBioscience. Phospho-ERK (clone 197G2) antibody was purchased from Cell Signalling and staining was performed in accordance with the manufacturer's recommendations. BrdU labelling. Mice were injected intraperitoneally with 1 mg of BrdU (BD Pharmingen) and killed at the indicated time points. BrdU staining was performed in accordance with the manufacturer's instructions. Biochemical analysis. For all biochemical analyses, Cnb1-deficient and control thymocytes were processed, stimulated and analysed as described in ref. 23 Microarray. Total RNA was harvested from sorted thymocytes with Trizol, followed by purification and on-column DNase digestion with an RNeasy mini kit (Qiagen) in accordance with the manufacturer's recommendations. Total RNA (200 ng) was used to generate biotinylated RNA with two rounds of amplification in accordance with Affymetrix's recommendation. All amplifications, antisense RNA labelling, hybridizations, washings, and data collection were performed by the Affymetrix Core Facility at the Stanford Protein and Nucleic Acid Facility. Data were analysed with GENESIS software 27 and GCOS and DMT software (Affymetrix) in accordance with the manufacturer's recommendations, leaving default settings unchanged.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
